• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体卒中:对COVID-19时代风险因素及最佳管理策略的重新评估

Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era.

作者信息

Boyke Andre E, Michel Michelot, Mamelak Adam N

机构信息

Department of Neurosurgery, Cedars-Sinai Medical Center, 127 S San Vicente Blvd, Los Angeles, CA, A6600, USA.

University of Florida College of Medicine, Gainesville, FL, USA.

出版信息

Pituitary. 2024 Dec;27(6):898-908. doi: 10.1007/s11102-024-01420-0. Epub 2024 Aug 5.

DOI:10.1007/s11102-024-01420-0
PMID:39102126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11632005/
Abstract

Pituitary apoplexy (PA) is a clinical syndrome caused by acute hemorrhage and/or infarction of the pituitary gland, most commonly in the setting of a pituitary macroadenoma. PA generally presents with severe headache, nausea, vomiting, visual disturbance, and, in more severe cases, altered mental status. Many factors have been attributed to the risk of developing PA, including most recently, numerous reports showcasing an association with COVID-19 infection or vaccination. Initial management of PA includes evaluation and correction of deficient hormones and electrolytes and an assessment if surgical decompression to relieve pressure on optic nerves and other brain structures is needed. While prompt recognition and treatment are crucial to avoid morbidity and mortality, in the modern era, PA is less commonly considered a true neurosurgical emergency requiring immediate (< 24 h) surgical decompression. Traditionally, surgical decompression has been the standard of care for significant mass effects. However, several studies have shown similar outcomes in visual and hormonal recovery with either surgical decompression or conservative medical management. Unfortunately, most evidence on optimal management strategies is limited to retrospective case series, small prospective studies, and one multi-center observational study. This review aims to provide the most up-to-date evidence on the role of COVID-19 in PA and best management strategies.

摘要

垂体卒中(PA)是一种由垂体急性出血和/或梗死引起的临床综合征,最常见于垂体大腺瘤的情况下。PA通常表现为严重头痛、恶心、呕吐、视觉障碍,在更严重的情况下,会出现精神状态改变。许多因素被认为与发生PA的风险有关,包括最近大量报告显示与COVID-19感染或疫苗接种有关。PA的初始治疗包括评估和纠正激素和电解质缺乏,并评估是否需要进行手术减压以减轻对视神经和其他脑结构的压力。虽然及时识别和治疗对于避免发病率和死亡率至关重要,但在现代,PA较少被视为需要立即(<24小时)进行手术减压的真正神经外科急症。传统上,手术减压一直是治疗明显占位效应的标准方法。然而,几项研究表明,手术减压或保守药物治疗在视觉和激素恢复方面的结果相似。不幸的是,关于最佳管理策略的大多数证据仅限于回顾性病例系列、小型前瞻性研究和一项多中心观察性研究。本综述旨在提供关于COVID-19在PA中的作用和最佳管理策略的最新证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3251/11632005/f99798b07e0b/11102_2024_1420_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3251/11632005/f99798b07e0b/11102_2024_1420_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3251/11632005/f99798b07e0b/11102_2024_1420_Fig1_HTML.jpg

相似文献

1
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era.垂体卒中:对COVID-19时代风险因素及最佳管理策略的重新评估
Pituitary. 2024 Dec;27(6):898-908. doi: 10.1007/s11102-024-01420-0. Epub 2024 Aug 5.
2
The role of intervention timing and treatment modality in visual recovery following pituitary apoplexy: a systematic review and meta-analysis.垂体卒中后视觉恢复中干预时机和治疗方式的作用:一项系统评价和荟萃分析
J Neurooncol. 2024 Dec;170(3):469-482. doi: 10.1007/s11060-024-04717-z. Epub 2024 Nov 6.
3
Diagnosis and Treatment of Pituitary Apoplexy, A True Endocrine Emergency.垂体卒中的诊断与治疗:真正的内分泌急症。
Arch Med Res. 2024 Jun;55(4):103001. doi: 10.1016/j.arcmed.2024.103001. Epub 2024 May 3.
4
SARS-CoV-2 Infection, A Risk Factor for Pituitary Apoplexy? A Case Series and Literature Review.SARS-CoV-2 感染是否是垂体卒中的危险因素?一项病例系列研究及文献复习。
Ear Nose Throat J. 2024 Jun;103(1_suppl):153S-161S. doi: 10.1177/01455613231179714. Epub 2023 Jun 8.
5
Revisiting Pituitary Apoplexy.垂体卒中再探讨。
J Endocr Soc. 2022 Jul 26;6(9):bvac113. doi: 10.1210/jendso/bvac113. eCollection 2022 Sep 1.
6
Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature.新型冠状病毒肺炎与垂体卒中:单中心病例系列研究及文献复习。
World Neurosurg. 2021 Aug;152:e678-e687. doi: 10.1016/j.wneu.2021.06.004. Epub 2021 Jun 12.
7
[Clinical practice guideline for the diagnosis and treatment of pituitary apoplexy].[垂体卒中诊断与治疗临床实践指南]
Endocrinol Nutr. 2013 Dec;60(10):582.e1-582.e12. doi: 10.1016/j.endonu.2013.04.013. Epub 2013 Sep 14.
8
Acute management of pituitary apoplexy--surgery or conservative management?垂体卒中的急性处理——手术还是保守治疗?
Clin Endocrinol (Oxf). 2004 Dec;61(6):747-52. doi: 10.1111/j.1365-2265.2004.02162.x.
9
Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection: a case series from Amiens University Hospital.感染 SARS-CoV-2 后继发垂体卒中:来自亚眠大学医院的病例系列研究。
Eur J Endocrinol. 2022 Jul 19;187(3):K19-K25. doi: 10.1530/EJE-22-0056. Print 2022 Sep 1.
10
Pituitary apoplexy associated with acute COVID-19 infection and pregnancy.与急性 COVID-19 感染和妊娠相关的垂体卒中。
Pituitary. 2020 Dec;23(6):716-720. doi: 10.1007/s11102-020-01080-w. Epub 2020 Sep 11.

引用本文的文献

1
Pituitary Apoplexy in a Child with Short Stature and Possible Recent SARS-CoV-2 Infection.一名身材矮小且近期可能感染新型冠状病毒的儿童发生垂体卒中。
Diagnostics (Basel). 2025 Jun 7;15(12):1453. doi: 10.3390/diagnostics15121453.
2
A Study in Pituitary Neuroendocrine Tumors (PitNETs): Real-Life Data Amid Baseline and Serial CT Scans.垂体神经内分泌肿瘤(PitNETs)研究:基线和系列CT扫描中的真实数据
Cancers (Basel). 2024 Oct 14;16(20):3477. doi: 10.3390/cancers16203477.

本文引用的文献

1
Mutations in the SARS-CoV-2 spike proteins affected the ACE2-binding affinity during the development of Omicron pandemic variants.在奥密克戎大流行变体发展过程中,SARS-CoV-2 刺突蛋白中的突变影响了 ACE2 的结合亲和力。
Biochem Biophys Res Commun. 2024 Jul 30;719:150120. doi: 10.1016/j.bbrc.2024.150120. Epub 2024 May 14.
2
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review.新型冠状病毒肺炎疫苗诱导的免疫性血栓性血小板减少症:综述
Clin Exp Vaccine Res. 2023 Oct;12(4):265-290. doi: 10.7774/cevr.2023.12.4.265. Epub 2023 Oct 31.
3
A Prospective, Multicenter, Observational Study of Surgical vs Nonsurgical Management for Pituitary Apoplexy.
前瞻性、多中心、观察性研究:垂体卒中的手术与非手术治疗。
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e711-e725. doi: 10.1210/clinem/dgad541.
4
SARS-CoV-2 Infection, A Risk Factor for Pituitary Apoplexy? A Case Series and Literature Review.SARS-CoV-2 感染是否是垂体卒中的危险因素?一项病例系列研究及文献复习。
Ear Nose Throat J. 2024 Jun;103(1_suppl):153S-161S. doi: 10.1177/01455613231179714. Epub 2023 Jun 8.
5
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review.垂体卒中与 COVID-19 疫苗接种:病例报告及文献复习。
Front Endocrinol (Lausanne). 2022 Nov 17;13:1035482. doi: 10.3389/fendo.2022.1035482. eCollection 2022.
6
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options.新冠病毒病中的内皮功能障碍:潜在机制与可能的治疗选择
Life (Basel). 2022 Oct 14;12(10):1605. doi: 10.3390/life12101605.
7
Pituitary apoplexy after COVID-19 vaccination: A case report.新型冠状病毒肺炎疫苗接种后垂体卒中:一例报告
J Clin Transl Endocrinol Case Rep. 2022 Sep;25:100123. doi: 10.1016/j.jecr.2022.100123. Epub 2022 Aug 4.
8
Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection: a case series from Amiens University Hospital.感染 SARS-CoV-2 后继发垂体卒中:来自亚眠大学医院的病例系列研究。
Eur J Endocrinol. 2022 Jul 19;187(3):K19-K25. doi: 10.1530/EJE-22-0056. Print 2022 Sep 1.
9
Sprouting Angiogenesis in Human Pituitary Adenomas.人类垂体腺瘤中的血管生成芽
Front Oncol. 2022 May 5;12:875219. doi: 10.3389/fonc.2022.875219. eCollection 2022.
10
Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination.基于腺病毒载体的新冠疫苗接种后垂体卒中
Brain Hemorrhages. 2023 Mar;4(1):27-29. doi: 10.1016/j.hest.2022.04.002. Epub 2022 Apr 19.